These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38519108)

  • 1. Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre.
    Zhou Z; Fang C; Wang L; Li J; Yang Y; Zhang L; Jin S; Zeng X; Tian X
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38519108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
    Koster MJ; Crowson CS; Giblon RE; Jaquith JM; Duarte-García A; Matteson EL; Weyand CM; Warrington KJ
    Ann Rheum Dis; 2022 Jun; 81(6):861-867. PubMed ID: 35190385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience.
    Spinelli FR; Ceccarelli F; Garufi C; Duca I; Mancuso S; Cipriano E; Dell'Unto E; Alessandri C; Di Franco M; Perricone C; Priori R; Riccieri V; Scrivo R; Sili Scavalli A; Truglia S; Valesini G; Conti F
    Clin Exp Rheumatol; 2021; 39(3):525-531. PubMed ID: 33337992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.
    Kong X; Sun Y; Dai X; Wang L; Ji Z; Chen H; Jin X; Ma L; Jiang L
    Ann Rheum Dis; 2022 Jan; 81(1):117-123. PubMed ID: 34362744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom.
    Eleftheriou D; Varnier G; Dolezalova P; McMahon AM; Al-Obaidi M; Brogan PA
    Arthritis Res Ther; 2015 Feb; 17(1):36. PubMed ID: 25879697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
    Sun Z; Li R; Wang Y; Han F; Wei W; Li X
    Drugs R D; 2023 Jun; 23(2):109-120. PubMed ID: 37010773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
    Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
    J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
    Reich K; Kabashima K; Peris K; Silverberg JI; Eichenfield LF; Bieber T; Kaszuba A; Kolodsick J; Yang FE; Gamalo M; Brinker DR; DeLozier AM; Janes JM; Nunes FP; Thyssen JP; Simpson EL
    JAMA Dermatol; 2020 Dec; 156(12):1333-1343. PubMed ID: 33001140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
    Guidelli GM; Viapiana O; Luciano N; De Santis M; Boffini N; Quartuccio L; Birra D; Conticini E; Chimenti MS; Bazzani C; Bruschi E; Riva M; Canziani LM; Bianchi G; Pozzi MR; Limonta M; Gorla R; Perricone R; Frediani B; Moscato P; De Vita S; Dagna L; Rossini M; Selmi C
    Clin Exp Rheumatol; 2021; 39(4):868-873. PubMed ID: 33338001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
    Mekinian A; Biard L; Lorenzo D; Novikov PI; Salvarani C; Espitia O; Sciascia S; Michaud M; Lambert M; Hernández-Rodríguez J; Schleinitz N; Awisat A; Puechal X; Aouba A; Munoz Pons H; Smitienko I; Gaultier JB; Edwige LM; Benhamou Y; Perlat A; Jego P; Goulenok T; Sacre K; Lioger B; Hassold N; Broner J; Dufrost V; Sené T; Seguier J; Maurier F; Berthier S; Belot A; Frikha F; Denis G; Audemard-Verger A; Koné-Paut I; Humbert S; Woaye-Hune P; Tomelleri A; Baldissera EM; Kuwana M; Lo Gullo A; Mukuchyan V; Dellal A; Gaches F; Zeminsky P; Galli E; Alvarado M; Boiardi L; Muratore F; Vautier M; Campochiaro C; Moiseev S; Vieira M; Cacoub P; Fain O; Saadoun D;
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37321669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
    Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
    Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study.
    Wang J; Dai X; Ma L; Wu S; Jin X; Ji Z; Chen H; Ma L; Ding Z; Jiang L; Kong X
    Semin Arthritis Rheum; 2022 Aug; 55():152018. PubMed ID: 35523066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study.
    Scheepers L; Yang Y; Chen YL; Jones G
    Semin Arthritis Rheum; 2024 Feb; 64():152314. PubMed ID: 38029717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
    Harigai M; Winthrop K; Takeuchi T; Hsieh TY; Chen YM; Smolen JS; Burmester G; Walls C; Wu WS; Dickson C; Liao R; Genovese MC
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32098857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.
    Karabacak M; Kaymaz-Tahra S; Şahin S; Yıldız M; Adroviç A; Barut K; Direskeneli H; Kasapçopur Ö; Alibaz-Öner F
    Semin Arthritis Rheum; 2021 Feb; 51(1):192-197. PubMed ID: 33383295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.